Propellant Health – Market Access Europe | Medical Devices

Propellant Health creates Market Access for innovative medical technologies.

Some of its results include:
Created EMEA go-to-market strategies for Silicon Valley genetic testing & automated cervical cancer screening
Determined go-to-market strategy and realized EMEA market access plan for Seattle-based Atossa Genetics; in breast cancer and pharmacogenomics
Successfully co-founded Hemacon GmbH; start-up in veterinary and human blood management systems
Created direct USA sales/service operations for producer of automated blood systems; revenues $10M+
Created go-to-market strategy for digital fundus camera based on scanning laser ophtalmoscope technology

Company’s Keywords:

radiology innovative systems, diagnostics technologies, key opinion leader identification & management, medical device strategic positioning